News Sentiment

CMPS sentiment intelligence

Compass Pathways Plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 63 Constructive news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 13.64 Week of 10 Jul 2026
Weighted tone 63/100

Constructive news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+0.1% over one week, +12.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

COMPASS Pathways (CMPS) Is Down 8.6% After Phase 3 Durability Data For COMP360 In TRD

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction 0.1% Price digesting
Trend fit Trend active 12.9% over four weeks
Fair value 102.7% Materially above fair value
Sentiment confirms active trend Positive but stretched

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 28
Neutral 24
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
Market source 6
simplywall.st 6
TradingView 6
Investing.com 6
TradingKey 3
Business Wire 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 13
Analyst action 5
Capital return 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
TradingView Direct company coverage

Price to earnings forward of COMPASS Pathways Plc - American Depository Shares – NASDAQ:CMPS

This article provides financial information for COMPASS Pathways Plc (CMPS) listed on the NASDAQ Stock Market, specifically focusing on its price-to-earnings forward ratio. The content appears to be a stub or an empty data table from TradingView, indicating that specific financia

Tone
Neutral 50/100
Event
Earnings
Published
29 Jun 2026 12:41
Source
TradingView
Investing.com Direct company coverage

Compass Pathways stock hits 52-week high at 14.77 USD

Compass Pathways Plc (CMPS) has hit a new 52-week high of $14.76, reflecting a robust 411% one-year stock performance and a market capitalization of $1.98 billion. This surge is attributed to investor confidence in the psychedelic therapy sector, recent positive Phase 3 data for

Tone
Positive 75/100
Event
Market update
Published
26 Jun 2026 16:10
Source
Investing.com
The Globe and Mail Direct company coverage

COMPASS Pathways (CMPS) Receives a Buy from H.C. Wainwright

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways (CMPS) with a price target of $70.00. Trucchio, a 5-star analyst, has a strong track record in the Healthcare sector. The company recently reported a significant net profit of $91.05 million for

Tone
Positive 70/100
Event
Analyst action
Published
26 Jun 2026 13:10
Source
The Globe and Mail
TradingView Direct company coverage

COMPASS Pathways Plc Sponsored ADR Actuals & Estimates (NASDAQ:CMPS)

This article provides an overview of COMPASS Pathways Plc (NASDAQ: CMPS) on TradingView, focusing on its financial actuals and estimates. It highlights reported financial data and analyst estimates across various financial statements and valuation metrics, allowing users to compa

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 23:09
Source
TradingView
TradingKey Direct company coverage

Compass Pathways PLC (CMPS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Compass Pathways PLC (CMPS) stock, focusing on its dividend and stock split history. It states that no dividends have been distributed over the past five years and no stock split data is available. The article also includes current stock price

Tone
Neutral 50/100
Event
Capital return
Published
18 Jun 2026 12:40
Source
TradingKey
TradingKey Direct company coverage

Compass Pathways PLC (CMPS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Compass Pathways PLC (CMPS), including analyst ratings, target prices, and EPS estimates. Based on 16 analysts, the stock has a "Buy" rating with an average target price of $21.719, representing an 89.02% upside. The report also high

Tone
Positive 71/100
Event
Earnings
Published
18 Jun 2026 07:40
Source
TradingKey
TradingKey Direct company coverage

Compass Pathways PLC (CMPS) Institutional Confidence

This article provides an overview of Compass Pathways PLC (CMPS) focusing on its institutional confidence, a component of its TradingKey Stock Score. It details institutional shareholdings and recent activity by significant investors, including changes in their positions. Key ins

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 06:40
Source
TradingKey
Psychedelic Alpha Direct company coverage

Compass Pathways IPO to Begin Trading 18th September on Nasdaq: CMPS

Compass Pathways has announced that its initial public offering of 7.5 million shares will begin trading on the Nasdaq Global Select Market today, September 18, 2020, under the ticker CMPS. The shares are priced at $17.00, raising gross proceeds of $127.5 million. The offering is

Tone
Positive 72/100
Event
Market update
Published
16 Jun 2026 03:40
Source
Psychedelic Alpha
Market source Direct company coverage

Transcript: Compass Pathways Q1 2026 Earnings Conference Call

Compass Pathways reported positive data from its Phase 3 studies of COM360 for treatment-resistant depression (TRD), showing rapid and durable efficacy. The company is preparing for a potential accelerated launch by the end of the year, backed by strong financials, ongoing FDA co

Tone
Positive 80/100
Event
Earnings
Published
06 Jun 2026 12:41
Source
Market source